戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y carboxylesterases, cytidine deaminase, and thymidine phosphorylase.
2 tions, and mutations in the nuclear gene for thymidine phosphorylase.
3 soDDU is completely resistant to cleavage by thymidine phosphorylase.
4 ble clinical syndrome caused by mutations in thymidine phosphorylase.
5 phosphorolytic activity was independent from thymidine phosphorylase.
6  factor, basic fibroblast growth factor, and thymidine phosphorylase.
7                                              Thymidine phosphorylase, a cellular enzyme markedly indu
8                                              Thymidine phosphorylase, a pyrimidine salvage enzyme, tr
9 several features of these patients including thymidine phosphorylase activity deficiency, elevated th
10                                              Thymidine phosphorylase activity rose from undetectable
11 ccur later in life, and may reflect residual thymidine phosphorylase activity.
12 ytes contained low levels of dTTP due to low thymidine phosphorylase activity.
13 s of 5-FU response: thymidylate synthase and thymidine phosphorylase activity; and p53 and mismatch r
14 ve TYMP mutations cause severe reductions of thymidine phosphorylase activity; marked elevations of t
15 ng the migration and signaling components of thymidine phosphorylase and 2-deoxyribose action.
16  the first to demonstrate a direct effect of thymidine phosphorylase and 2-deoxyribose on signaling p
17                       Here we show that both thymidine phosphorylase and 2-deoxyribose stimulated the
18                                     Further, thymidine phosphorylase and 2-deoxyribose, but not VEGF,
19                                              Thymidine phosphorylase and 2-deoxyribose-induced focal
20 sion of alpha 5 beta 1 was also increased by thymidine phosphorylase and 2-deoxyribose.
21 tes several proangiogenic factors, including thymidine phosphorylase and angiopoietin-1 both in vitro
22 the intracellular metabolism of thymidine by thymidine phosphorylase and subsequent extracellular rel
23                                              Thymidine phosphorylase and uridine phosphorylase double
24                            Recombinant human thymidine phosphorylase catalyzes the reaction of arsena
25 ointestinal encephalomyopathy and had severe thymidine phosphorylase deficiency in the buffy coat (<1
26 l recessive multisystemic disorder caused by thymidine phosphorylase deficiency.
27 disease due to TYMP mutations that result in thymidine phosphorylase deficiency.
28 r vascular endothelial growth factor (VEGF), thymidine phosphorylase differed from VEGF in that its e
29 ccur from docetaxel-mediated upregulation of thymidine phosphorylase (dThdPase), an enzyme responsibl
30    Two new crystal forms of Escherichia coli thymidine phosphorylase (EC 2.4.2.4) have been found; a
31 oietic stem cell transplantation can restore thymidine phosphorylase enzyme function in patients with
32                                Based on high thymidine phosphorylase expression in the liver, a 25-ye
33  Cdk5 (cyclin-dependent kinase 5) from Cdk2, thymidine phosphorylase from a bacterial homologue, and
34  and control brains, indicating that loss of thymidine phosphorylase function impairs the integrity o
35 mine and deoxyribose-1-phosphate by the host thymidine phosphorylase greatly increases the sensitivit
36                                              Thymidine phosphorylase has been implicated in angiogene
37                          Overexpressed human thymidine phosphorylase (hTP) has been associated with c
38                                        Human thymidine phosphorylase (hTP) is responsible for thymidi
39                                        Human thymidine phosphorylase (hTP) is responsible for thymidi
40 hanisms by which 2-deoxyribose might mediate thymidine phosphorylase-induced cell migration in vitro,
41                                              Thymidine phosphorylase is an angiogenic factor that is
42 ase caused by mutations in the gene encoding thymidine phosphorylase, leading to reduced enzymatic ac
43 e synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, microsatellite instability, 18q
44 e in thymidylate synthase and an increase in thymidine phosphorylase mRNA expression as determined by
45                          The enzyme/cytokine thymidine phosphorylase/platelet-derived endothelial cel
46  of the transition state confirms that human thymidine phosphorylase proceeds through an S(N)2-like t
47                                              Thymidine phosphorylase replacement has been achieved by
48 revious studies showed that cells expressing thymidine phosphorylase stimulated endothelial cell migr
49 s-of-function mutations in the gene encoding thymidine phosphorylase (TP) a cytosolic enzyme.
50               Accordingly, we have generated thymidine phosphorylase (TP) and uridine phosphorylase (
51                                              Thymidine phosphorylase (TP) catalyzes the reversible ph
52 essive human disease due to mutations in the thymidine phosphorylase (TP) gene.
53    The disease is caused by mutations in the thymidine phosphorylase (TP) gene.
54                                              Thymidine phosphorylase (TP) is an angiogenic growth fac
55                                              Thymidine phosphorylase (TP) is an important target enzy
56 ic pyrimidine nucleoside inhibitors of human thymidine phosphorylase (TP) is described.
57                        The angiogenic factor thymidine phosphorylase (TP) is highly expressed in huma
58                        The angiogenic factor thymidine phosphorylase (TP) is highly expressed in many
59 ne kinase 1 (TK1), thymidylate synthase, and thymidine phosphorylase (TP) were analyzed by Western bl
60 ioned medium from Smo- mice were depleted of thymidine phosphorylase (TP), a protein that maintains m
61 eterozygous mutations in the gene specifying thymidine phosphorylase (TP), located on chromosome 22q1
62  with nuclease P1, alkaline phosphatase, and thymidine phosphorylase (TP), or from chlorinated nucleo
63  by mutations in TYMP gene, encoding nuclear thymidine phosphorylase (TP).
64  is caused by mutations in the gene encoding thymidine phosphorylase (TP).
65 s-of-function mutations in the gene encoding thymidine phosphorylase (TP).
66                                              Thymidine phosphorylase (TP; also known as platelet-deri
67 s-of-function mutations in the gene encoding thymidine phosphorylase (TP; endothelial cell growth fac
68             Calciphylaxis serum up-regulated thymidine phosphorylase (TYMP) in ECs.
69                   Platelets contain abundant thymidine phosphorylase (TYMP), which is highly expresse
70  such as TYMS, thymidine kinase 1 (TK-1) and thymidine phosphorylase (TYMP).
71                        Here, we now identify thymidine phosphorylase (TYMP; previously known as endot
72 ct of thymidine catalyzed by the function of thymidine phosphorylase, upregulates CIITA expression in